Note 7 - Net Income (Loss) Per Share

9 Months Ended

Sep. 30, 2023

Notes to Financial Statements

Earnings Per Share [Text Block]

7. Net Income (Loss) Per Share

The calculations of net income (loss) per share were as follows:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2023		2022			2023			2022
	(Unaudited - In thousands, except per share data)
Basic:
Net income (loss)	$	932	$	(3,164	)	$	(5,414	)	$	(9,390	)
Weighted average common shares outstanding		16,285		16,281			16,167			16,405
Net income (loss) per share	$	0.06	$	(0.19	)	$	(0.33	)	$	(0.57	)
Diluted:
Net income (loss) for dilutive share computation	$	932	$	(3,164	)	$	(5,414	)	$	(9,390	)
Number of shares used in basic per share computation		16,285		16,281			16,167			16,405
Unvested restricted stock and DSU's		—		—			—			—
Employee stock options		—		—			—			—
Weighted average common shares outstanding		16,285		16,281			16,167			16,405
Net income (loss) per dilutive share	$	0.06	$	(0.19	)	$	(0.33	)	$	(0.57	)

Basic and diluted average common shares outstanding for purposes of computing net income (loss) per share includes outstanding common shares and vested deferred stock units (DSUs).

If an equity method company has dilutive stock options, unvested restricted stock, DSUs or warrants, diluted net income (loss) per share is computed by first deducting from net income (loss) the income attributable to the potential exercise of the dilutive securities of the company from net income (loss). Any impact is shown as an adjustment to net income (loss) for purposes of calculating diluted net income (loss) per share.

Diluted income (loss) per share do not reflect the following potential shares of common stock that would have an anti-dilutive effect or have unsatisfied performance or market conditions:

• At September 30, 2023 and 2022, options to purchase 8 thousand and 18 thousand shares of common stock, respectively, a price of $10.37 and a range of $10.37 to $17.11, respectively, were excluded from the calculations.

• At September 30, 2023 and 2022, unvested restricted stock and performance-based stock units convertible into 0.3 million and 0.2 million shares of stock, respectively, were excluded from the calculations.

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)